Table 1.
Demographic and clinical characteristics before and after PSM.
| Before PSM | After PSM | |||||
|---|---|---|---|---|---|---|
| MAID Cohort (n = 149) a | Full Non-MAID Cohort (n = 486) a | p | MAID Cohort (n = 149) a | Matched Non-MAID Cohort (n = 149) a | p | |
| Age at death [mean (SD)] | 68.7 (11.8) | 72.5 (12.6) | .001 | 68.7 (11.8) | 67.4 (11.2) | .346 |
| Sex: | .499 | .163 | ||||
| Female | 74 (49.7%) | 226 (46.5%) | 74 (49.7%) | 62 (41.6%) | ||
| Male | 75 (50.3%) | 260 (53.5%) | 75 (50.3%) | 87 (58.4%) | ||
| Marital status: | .677 | .557 | ||||
| Married/in common-law relationship | 84 (56.4%) | 227 (58.4%) | 84 (56.4%) | 89 (59.7%) | ||
| Single/widowed/divorced/separated | 65 (43.6%) | 162 (41.6%) | 65 (43.6%) | 60 (40.3%) | ||
| Rurality: | .000 | .712 | ||||
| Metro | 113 (75.8%) | 282 (58.1%) | 113 (75.8%) | 112 (75.2%) | ||
| Urban | 16 (10.7%) | 66 (13.6%) | 16 (10.7%) | 13 (8.7%) | ||
| Rural | 20 (13.4%) | 137 (28.2%) | 20 (13.4%) | 24 (16.1%) | ||
| Neighborhood-level income quintile: | .005 | .461 | ||||
| 1 (USD 19,968–USD 62,933) (lowest) | 22 (14.8%) | 100 (20.7%) | 22 (14.8%) | 30 (20.1%) | ||
| 2 (USD 63,040–USD 77,248) | 25 (16.8%) | 112 (23.2%) | 25 (16.8%) | 31 (20.8%) | ||
| 3 (USD 77,312–USD 96,000) | 23 (15.4%) | 94 (19.5%) | 23 (15.4%) | 17 (11.4%) | ||
| 4 (USD 96,256–USD 120,064) | 33 (22.1%) | 91 (18.8%) | 33 (22.1%) | 26 (17.4%) | ||
| 5 (USD 120,192–USD 312,320) (highest) | 46 (30.9%) | 86 (17.8%) | 46 (30.9%) | 45 (30.2%) | ||
| Birth country: | .208 | .878 | ||||
| Canada | 125 (83.9%) | 306 (79.1%) | 125 (83.9%) | 124 (83.2%) | ||
| Outside of Canada (high income) | 24 (16.1%) | 81 (20.9%) | 24 (16.1%) | 25 (16.8%) | ||
| Tumor group: | .003 | .899 | ||||
| Breast | 13 (8.7%) | 46 (9.5%) | 13 (8.7%) | 13 (8.7%) | ||
| Gastrointestinal | 44 (29.5%) | 150 (30.9%) | 44 (29.5%) | 43 (28.9%) | ||
| Genitourinary | 14 (9.4%) | 55 (11.3%) | 14 (9.4%) | 21 (14.1%) | ||
| Gynecology | 17 (11.4%) | 24 (4.9%) | 17 (11.4%) | 14 (9.4%) | ||
| Hematology | 15 (10.1%) | 51 (10.5%) | 15 (10.1%) | 12 (8.1%) | ||
| Lung | 23 (15.4%) | 122 (25.1%) | 23 (15.4%) | 25 (16.8%) | ||
| Other b | 23 (15.4%) | 38 (7.8%) | 23 (15.4%) | 21 (14.1%) | ||
| Age at diagnosis: | .000 | .948 | ||||
| Mean (SD) | 64.0 (12.3) | 69.2 (13.1) | 64.0 (12.3) | 64.1 (10.8) | ||
| CCI: | .000 | .900 | ||||
| 0 | 104 (69.8%) | 207 (42.6%) | 104 (69.8%) | 103 (69.1%) | ||
| ≥1 | 45 (30.2%) | 279 (57.4%) | 45 (30.2%) | 46 (30.9%) | ||
a The sample size for each variable may differ from the total cohort size, due to some patients having missing data for certain characteristics. b Other includes Central Nervous System, endocrine, head-and-neck, melanoma, non-melanoma skin, sarcoma, and other malignant cancers.